Moxifloxacin: A review of its in vitro activity, clinical efficacy, and adverse effects

Pharmacology, Toxicology and Pharmaceutical Science

• Moxifloxacin 100%
• Infection 60%
• Clarithromycin 40%
• Organisms 20%
• Azithromycin 20%
• Community Acquired Pneumonia 20%
• Cefuroxime Axetil 20%
• Amoxicillin 20%
• Quinolone Derivative 20%
• Adverse Event 20%
• Drug Interaction 20%
• Pharmacodynamics 20%
• Respiratory Tract Infection 20%
• Chronic Bronchitis 20%
• Cefalexin 20%
• Hospital Infection 20%
• Quinoline Derived Antiinfective Agent 20%
• Sinusitis 20%
• Clinical Trial 20%